by BioKier | Jul 13, 2016 | Recent News
Australian Patent Office has accepted BioKier patent application number 2012250877 and a notice of the acceptance will appear in the Supplement to the Australian Official Journal of Patents on 21 July 2016. The present invention relates to a method of treating...
by BioKier | Jun 9, 2016 | Recent News
BioKier has been informed by European Patent Office that the examining division intends to grant a European patent on the basis of the application # 10 729 620.4 The present invention relates to a method of treating an incretin related disease such as diabetes,...
by BioKier | Apr 17, 2016 | Recent News
US PTO has granted BioKier patent 9,301,938 which was issued on April 5, 2016. The present invention relates to a method of treating obesity, diabetes and other metabolic diseases by fixed combination of BioKier’s product with monoamine reuptake inhibitors like...
by BioKier | Jan 14, 2016 | Recent News
US PTO has granted BioKier patent 8,470,885 which published on June 25, 2013 Second BioKier patent issued by US PTO on 3/25/14; Patent Number: 8,680,085 Third BioKier patent issued by US PTO on 4/14/15; Patent Number: 9,006,288
by BioKier | Jan 14, 2016 | Recent News
BioKier presentation at 75th Scientific Sessions of the American Diabetes Association Meeting Dr. George Szewczyk on behalf of BioKIer presented poster at the 75th American Diabetes Association Meeting held in Boston, June 5 – 9, 2015. Poster was entitled...
by BioKier | Jan 14, 2016 | Recent News
BioKier has been awarded a $1.6 million Fast-Track Small Business Innovation Research (SBIR) Grant by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of The National Institutes of Health (NIH), to support pre-clinical and...
